Recognising Industry's Finest
The MTAA MedTech Industry Awards celebrate the people, companies and technologies driving innovation and improving health outcomes across Australia.
Each year, we recognise outstanding contributions that advance patient care, champion sustainability, strengthen partnerships, and showcase the transformative power of medical technology.
By highlighting these achievements, we honour the leaders and innovators shaping the future of MedTech.
Kerrin Rennie Award Finalists
We are proud to announce the finalists for the prestigious Kerrin Rennie Award for 2025.
Medtronic Australasia - Sphere-9 Catheter and Affera Mapping and Ablation System
Medtronic’s Affera Mapping and Ablation System featuring the innovative Sphere-9 catheter is transforming and revolutionising cardiac care by uniting high-resolution mapping and dual-energy ablation—pulsed field and radiofrequency—into one device.
The conformable nitinol lattice tip delivers precise, tailored therapy with enhanced safety, while eliminating the need for multiple tools. This innovation allows physicians to treat a range of arrhythmias in one procedure, shortens procedure time, lowers costs, reduces radiation exposure, and supports same-day discharge.
Clinical studies show superior lesion durability, fewer repeat procedures, and zero major safety events, enabling hospitals to treat more patients efficiently while transforming patient outcomes and quality of life.
Device Technologies / SamanTree Medical- Histolog Scanner
SamanTree Medical’s Histolog Scanner (distributed by Device Technologies) is a groundbreaking medical device that allows for the real-time detection of cancer cells during surgery, thereby enhancing precision and reducing the necessity for repeat procedures.
It has already been implemented in the most prevalent cancers in Australia, breast and prostate cancer, and it provides results within 10 minutes, enabling surgeons to act immediately and improve the quality of life and safety of patients.
The Histolog Scanner is a significant advancement in cancer treatment as it provides a practical, intraoperative alternative to frozen section and lab-based analysis.
3D Morphic - 3DMorphic Patient Specific Interbody Fusion Cage
Edward Lifesciences - Sapien 3 Ultra RESILIA (S3UR)
The Edwards Sapien 3 Ultra RESILIA offers patients with severe aortic stenosis the prospect of a healthier, extended life.
The fifth generation of Edwards’ transcatheter heart valve expands upon two decades of innovation and investment, culminating in RESILIA tissue technology.
This cutting-edge calcium-blocking process improves durability and minimises the necessity for subsequent interventions, thereby addressing the primary cause of tissue valve failure.
Sapien 3 Ultra RESILIA provides patients with a renewed quality of life, safer outcomes, and enduring protection.
Award Sponsor
About the Award
The Kerrin Rennie Award for Excellence in Medical Technology honours outstanding innovation in the delivery of patient care.
Named in memory of Kerrin Rennie, a passionate advocate for advancing healthcare through MedTech, the award recognises breakthrough technologies that demonstrate a significant impact on patient outcomes, safety, and quality of life.
Who is Kerrin Rennie?
The Kerrin Rennie Award for Excellence in Medical Technology – Improving Quality of Life was established to recognise and profile the innovative and extraordinary contribution of medical technology in improving health outcomes of Australian patients.
The Award was inaugurated in 2007 and is endowed by the Rennie family in memory of Kerrin; a long serving and highly respected member of the Australian medical technology community.
Kerrin Rennie (formerly Kerrin McKenna) was the Managing Director of ConvaTec, a member company of Medical Industry Association of Australia (now MTAA). Kerrin was elected to the Board of MIAA in 1996, becoming its first female member. She was an active and enthusiastic member of the Board and an advocate for greater involvement of women at senior levels in the industry. In that capacity, Kerrin was instrumental in the recruitment to the Board of Maureen McKenzie (Coloplast), who became the Association’s first female Chair.
Kerrin was appointed Honorary Treasurer in 1996 and served two terms in that office, retiring from the Board in 1999. She was an active member of several MIAA committees, including the Stoma Appliance and Wound Care Special Interest Groups. A trained nurse, Kerrin never lost sight of the central mission of our industry, that of caring for patients. She was a passionate advocate for the contribution of medical technology in extending life and improving the quality of life.
Previous Winners
About the Award
The Outstanding Achievement Award recognises an individual who has contributed in an exceptional way to the medical technology industry in Australia. This may be evidenced through their contribution to industry development, improvement in patient outcomes or excellence in leadership and/or innovation.
Previous Winners
2024: Falko Theile, BIOTRONIK
Falko, as Director of Clinical and Regulatory Affairs at BIOTRONIK, brings over 25 years of expertise in enhancing outcomes for cardiac patients in Australia and New Zealand. His dynamic presence within MTAA committees has driven positive changes benefiting countless patients. Falko’s representation of the industry is marked by his unwavering passion, infectious sense of humour, and highly respected insights, shaping policies and garnering respect from industry colleagues and government officials.
2023: Liz Carnabuci, Medtronic
Liz is an experienced and strategic communicator with more than 25 years of sales and marketing experienced in the healthcare industry in ANZ, China and APAC markets. She is committed to commercial excellence and is passionate about developing people and designing programmes to build talent, promote inclusion and drive organisational success. She is very passionate about healthcare and helping ensure that Australia continues to provide a sustainable and world-class healthcare system that can be accessed by everyone.
Liz is currently Vice President, Enterprise Accounts and Services for Medtronic ANZ and Japan and is also Vice President Asia Pacific and Greater China for Medtronic’s Diabetes business.
As one of MTAA’s Board of Directors, she has a solid understanding of the duties and key governance principles and strategies to drive board success.
2022: Doug Symonds, Medtronic
Over the last two years, Doug Symonds has played a leading and crucial role in supporting the industry through driving PL Reforms.
Doug is an active member of the Reimbursement Committee – and has led critical work involving the committee and it’s multiple workstreams/groups. This included supporting the MTAA with its negotiations on PL reforms objectives and most recently, the signing of the Memorandum of Understanding for the policy parameters of the Prostheses List Reforms.
He also worked with the Department and the MTAA on the PL assessment pathways, PL re-grouping, and bundling work to help determine alternative funding mechanisms with respect to general use items being taken off the PL.
In addition to his role on the Reimbursement Committee, he is also an active member of the MTAA Cardiac Forum at which he played a key role in helping establish an additional review on technical services.
Doug’s knowledge, experience, expertise and passion as well as his contributions over the last two years demonstrate that he is a strong advocate of the Medical Technology Industry’s goals and objectives.
2021: Warren Bingham, MedTech International
Warren is being recognised for his role in improving the lives of thousands of people, expanding clinical practice for hundreds of Gastroenterologists helping them to save lives and enhance human health.
Warren has been a representative for several industry groups including the AusMedtech’s National Advisory Committee, chair of the Medtech and Life-science committee of the Australia/Israel Chamber of Commerce and currently a Board member of Research Australia.
Outstanding Achievement Award Finalists
We are proud to announce the finalists for the Outstanding Achievement Award for 2025.
Craig Neylon
Dr Craig Neylon has transformed Victoria’s MedTech sector by bridging local manufacturers with government procurement.
As a former ICN MedTech Adviser at Industry Capability Network Victoria, he facilitated $81 million in contracts for 242 local suppliers. He embedded MedTech requirements into $7.3 billion of health projects and created the first MedTech Capability Directory of 103 manufacturers.
Through industry showcases, site visits, and collaborations, Craig has strengthened supply chains, advanced policy integration, and established pathways for small to medium enterprises, laying the foundations for a sustainable and competitive MedTech industry.
Tze Yan Chia
Michael Simmonds
Michael Simmonds has been a cornerstone of industry leadership during the most significant reform period in MedTech’s history.
As Director of Health Economics & Government Affairs at Boston Scientific and long-serving Chair of MTAA’s Reimbursement Committee, Michael provided crucial support for two critical MOUs with the Federal Health Minister that safeguarded patient access to innovative devices.
His strategic advocacy played a significant role in minimising the impact of PHI reform, delivered major industry savings, and ensured reimbursement systems support sustainability, advancing innovation and better patient outcomes nationwide.
MedTech Compass Award Finalists
We are proud to announce the finalists for the MedTech Compass Award for 2025.
New Medtek Devices - RrhoidCath
RrhoidCath™ by New Medtek Devices is redefining pain management after one of the most painful surgeries, haemorrhoidectomy.
This innovative wearable system delivers local anaesthetic directly to the surgical site, reducing opioid reliance, hospital stays, and recovery times.
In clinical trials, 75% of patients reported zero pain compared to 40% under standard care. With a seasoned leadership team and ARTG registration issued, RrhoidCath™ represents a breakthrough in post-operative care, tackling a global need for safer, more effective recovery.
Cartago Biotech - CBT005
Cartago Biotech’s CBT005 is a groundbreaking treatment for chronic low back pain, one of Australia’s leading causes of disability.
Delivered as a single intradiscal injection under local anaesthetic, CBT005 stimulates the body’s own stem cells to regenerate spinal discs, relieving pain and restoring movement. This minimally invasive therapy bridges the gap between conservative treatments and surgery, reducing complications and recovery time.
With scalable manufacturing, compelling preclinical evidence, and strong health economic potential, CBT005 offers a transformational, evidence-based solution to reshape spine care in Australia and worldwide.
Baymatob - Oli
Baymatob’s Oli is an AI-powered wearable and digital health platform delivering a revolutionary step-change in maternal and foetal monitoring. It provides clinicians with novel insights to shift care from reactive to proactive.
Oli offers world-first information on pregnancy and labour, including early warning for severe but treatable complications.
The first capability being taken to market targets postpartum haemorrhage—the leading cause of preventable maternal death, affecting ~1 in 5 births in Australia. With 93% of deaths avoidable through earlier intervention, Oli helps reduce outcomes such as birth trauma, transfusions, and hysterectomy.
About the Award
About the Award
Tech4Health Award Finalists
We are proud to announce the finalists for the Tech4Health Award for 2025.
Medtronic Australasia - FocusOn™
Net-Health - Net-HealthData™
Net-HealthData™ is redefining care for women with gestational diabetes, delivering 24/7 monitoring in the comfort of their home.
Used by more than 5,000 women across Australia, it transmits real-time data to clinicians and integrates with CHOConnect, a multilingual app offering secure messaging, education, and reassurance. Patients feel empowered and supported, while clinicians save vital time without compromising care.
By combining cutting-edge technology with compassion, Net-HealthData™ is making high-risk pregnancy safer, smarter, and more supportive than ever before.
Vantive - MyPD Remote Patient Management for Peritoneal Dialysis Patients
MyPD mobile app for patients is breaking down barriers to home dialysis by giving every peritoneal dialysis patient the confidence and support to manage treatment safely at home.
For the first time, both manual and automated peritoneal dialysis patients can benefit from remote monitoring, reassuring patients, empowering clinicians, and reducing hospital visits.
By preserving kidney function, improving quality of life, and cutting costs to one-third of in-centre care, MyPD is ensuring the long-term sustainability and resilience of Australia’s health system by enabling more patients to undertake dialysis at home.
Leader In Greennovation Award Finalists
We are proud to announce the Leader in Greennovation Award for 2025.
Medtronic Australasia - Medtronic Australasia in Partnership with Hoxton Industries
Medtronic’s partnership with Hoxton Industries has diverted over 200 tonnes of waste from landfill, with 93.1% recycled into construction and automotive inputs, while creating stable employment for 35 people with disabilities.
The Cardiac Monitor Refurbishment Program has repurposed 8,000 devices, avoiding 3.5 tonnes of e-waste.
Logistics innovations, including a Pick-to-Box system, cut packaging waste and reduced freight volume by 9,000kg annually.
This initiative actively accelerates Medtronic’s progress toward their 2030 carbon neutrality and 2045 net zero goals, proving that environmental leadership and community value can be achieved together.
Smartways Logistics - SUSTAINABILITY NOW
Sustainability is Smartways’ operational standard, not an aspiration.
As Australasia’s only 100% carbon-neutral healthcare logistics provider, Smartways Logistics deliver urgent, life-saving shipments without compromising clinical outcomes or patient results.
They ensure a sustainable and affordable healthcare supply chain by fully funding carbon mitigation and offsetting for their partners. This unparalleled commitment to integrity and leadership is certified by their Dual Climate Active accreditations.
Beyond transport, they eliminate single-use packaging, employ reusable thermal solutions, paperless systems, and green procurement.
Their “Logistics for Life” motto is testament to their commitment to the patient as well as the environment, positioning Smartways as a true sustainability leader.
Cardinal Health - Remanufacturing of Single-Use Devices (SUDs)
Cardinal Health is set to redefine healthcare sustainability in Australia by remanufacturing single-use medical devices – reducing landfill impact, enabling reuse and prolonging device lifespan through advanced cleaning and disinfection.
Nationwide, more than 10 tonnes of medical devices have already been collected to power this initiative, centred around a purpose-built facility in Beresfield, New South Wales.
This initiative reflects Cardinal Health’s commitment to scalable, sustainable innovation and is poised to deliver measurable results – strengthening Australian manufacturing, creating jobs, and improving supply chain resilience while positioning Australia as a leader in sustainable MedTech production.
About the Award
About the Award
The MTAA Women in MedTech mission aims to proactively support gender diversity within the MedTech industry, effectively supporting women to unlock their full potential.
The Women in MedTech – Company Champion Award recognises a company that has been a key contributor to demonstrating leadership and advancing diversity, equity, and inclusion in Australia.
Women in MedTech Company Champion Award Finalists
We are proud to announce the Women in MedTech Company Champion Award for 2025.
Medtronic Australasia
Medtronic Australasia is redefining inclusion, diversity, and equity through measurable progress and bold leadership.
Female representation in Medtronic’s leadership has risen from under 35% in 2022 to 48.5% in 2025, driven by initiatives such as EmpowerME and the MOVE Mentorship Program. Medtronic is targeting 45% sustained female leadership by 2026 and reducing the gender pay gap by 8%.
Medtronic also offers flexible work, enhanced parental leave, and ERGs like Project Hope that deliver systemic and community impact.
Recognised as a Great Place to Work and WGEA Employer of Choice, Medtronic is empowering the next generation of leaders in MedTech.
Stryker
Stryker is advancing diversity, equity, and inclusion through measurable, sustained action.
Employing 978 people across Australia and New Zealand, women now make up 49.6% of staff, 51.7% of leaders, and 54% of the Senior
Leadership Team—demonstrating steady growth from 43% in 2023.
Stryker has introduced inclusive hiring, strengthened parental support, and championed gender equity in sales and engineering.
Through industry panels, training, and partnerships, Stryker is shaping a culture where all employees thrive while driving sector-wide progress in diversity, equity, and inclusion.
Vantive
Vantive launched as a new company in February after the separation of the Kidney Care business of Baxter Healthcare, and has established itself as a champion for women in MedTech. Building on a decade as a WGEA Employer of Choice, Vantive strongly supports MTAA’s Women in MedTech mission, driving equality and leadership across the industry.
Key initiatives include the ALLIANCE FOR WOMEN Employee Resource Group, leadership development programs, flexible work policies, and active female stakeholder engagement. With integrity and inclusion embedded in its culture and operations, Vantive is empowering women and men, strengthening the MedTech sector, and expanding its impact as an independent organisation.
Women in MedTech Individual Champion Award Finalists
We are proud to announce the Women in MedTech Individual Champion Award for 2025.
Aviva Assouline - Medtronic Australasia
Aviva Assouline has spent over a decade driving innovation and equity in diabetes care.
From launching world-first technologies in Australia and New Zealand to leading Medtronic’s regional growth across the Asia Pacific, her leadership was recognised with the company’s prestigious Star of Excellence Award.
Now as Senior Director of ANZ Diabetes, Aviva leads a 70-strong team deeply connected to the patient community.
As a mentor and advocate for diverse leadership, Aviva ensures the patient voice remains central while championing women across the industry.
Rebecca Meehan - Medtech Women's Coach
Rebecca is a passionate advocate for gender equity in MedTech, with a legacy of building mentorship, advocacy, and community.
A founding member of Boston Scientific’s APAC Women’s ERG, she created a mentorship program connecting hundreds, later leading Boston ANZ’s ERG and Alcon’s Gender Equality Committee.
In 2024, she founded Medtech Women’s Coach to empower women and allies industry-wide.
Guided by “progress, not perfection,” Becca uplifts others with empathy, vision, and collective impact.
Helen Souris - Cardihab
Helen Souris is a digital health leader who blends commercialisation and regulatory expertise with a strong commitment to diversity, equity, and inclusion in MedTech.
At Cardihab, she transformed a CSIRO spin-out into a TGA-registered digital therapeutic three years ahead of regulation, demonstrating how compliance creates competitive advantage and market access.
She champions inclusive, collaborative leadership, team diversity and advocates for equitable pathways in cardiovascular disease prevention and management.
By embedding DE&I into strategy and ecosystem design, Helen ensures digital health solutions are scalable, accessible, and transformative for patients and industry.
Jane Walton - Vantive
Jane’s leadership at Vantive ANZ has advanced patient-centred innovation in peritoneal dialysis while embedding inclusion across the organisation.
As a Senior Leadership Team member and DE&I Steering Committee delegate, she spearheaded the Alliance for Women ERG, driving campaigns on gender equity, breast cancer, and domestic violence awareness.
Externally, she hosted industry events spotlighting bias in healthcare, while internally she mentors, upskills, and empowers talent.
By blending digital strategy, market access expertise, and inclusive leadership, Jane delivers measurable patient impact and cultural transformation within MedTech.
About the Award
The MTAA Women in MedTech mission aims to proactively support gender diversity within the MedTech industry, effectively supporting women to unlock their full potential.
The Women in MedTech – Individual Champion Award honours an individual who has made significant contributions to advancing diversity, equity, and inclusion within the medical technology industry.
Award Sponsor
About the Award
The MTAA Women in MedTech mission aims to proactively support gender diversity within the MedTech industry, effectively supporting women to unlock their full potential.
The Women in MedTech – Emerging Women in Leadership Award celebrates an inspiring and rising female leader with the medical technology industry. This award is exclusively for MTAA members.
Women in MedTech: Emerging Women in Leadership Award Finalists
We are proud to announce the Women in MedTech: Emerging Women in Leadership Award for 2025.
Lauren Gaw - Medtronic Australasia
Lauren Gaw’s journey is a testament to the power of turning pain into purpose.
After the tragic loss of her daughter Hope, Lauren Gaw transformed grief into purpose by founding “Project Hope” to ensure no colleague would endure loss alone.
Now co-chair of the Medtronic Women’s Network, Lauren has amplified gender equity initiatives and created meaningful programs that empower women across the organisation.
Her courage, empathy, and determination have reshaped Medtronic’s culture, inspiring others and leaving a lasting impact. Lauren is proof that lived experience can drive extraordinary leadership.
Honorah Lowe - Vantive
With a decade of frontline experience as a Paediatric ICU nurse, Honorah Lowe transitioned into MedTech sales and, in just five years, has emerged as a truly transformational leader at Vantive A.N.Z.
Her unique ability to fuse deep clinical insight with commercial acumen has yielded exceptional results, earning her the prestigious Commercial Person of the Year award twice and the 2024 Vantive Global Elite Award.
Honorah’s impact is felt across the business: she drives commercial excellence through innovative initiatives like her ICU webinars that accelerate the adoption of Acute Therapies; she champions an inclusive culture through her work with ERGs; and she fuels Vantive’s future talent pipeline by passionately mentoring new hires and improving onboarding.
Samantha Tate - Edwards Lifesciences
Samantha Tate exemplifies visionary leadership through strategic initiatives, community engagement, and empowerment of others.
As lead author of Heartbeat magazine, she has transformed internal communications into a unifying cultural cornerstone.
From 2024–2025, she advanced gender equity as a leader in the Edwards Network of Women, coordinating events including the acclaimed Women in Leadership Summit.
Beyond the workplace, Samantha drives impactful community partnerships with organisations such as Ronald McDonald House and Youth Off The Streets.
These efforts, driven by her signature blend of empathy, professionalism, and purpose, have cemented her reputation as a respected and transformative leader.
Award Categories
Click on the Award to learn more
